45
Lucier Pharmaceuticals raises $2M in Texas under Reg D 506(b)
Company raise · Pre-first close · BRYAN, TX · Form D filed 2026-10-13
Lucier Pharmaceuticals, a Texas-incorporated pharmaceutical company founded in 2023, is raising up to $2M from accredited and non-accredited investors with a $10K minimum. The company has filed its first Form D and has yet to close its initial sale.
Note: Company is pre-first-close with three investors listed but $0 sold; founder Guangrong Lu recently relocated business from home address to Bryan, TX. Non-accredited investors present under 506(b) exemption.
First raise on EDGARNon-accredited investorsoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Guangrong Lu Lu | CEO and the issuer is the same person. Lcuier was originally registered at his home address. New business address is in Bryan, TX recently. |
Signed by Guangrong Lu, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.